Log in
Enquire now
‌

US Patent 10125102 Human plasma kallikrein inhibitors

Patent 10125102 was granted and assigned to BioCryst Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals
Current Assignee
BioCryst Pharmaceuticals
BioCryst Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10125102
Date of Patent
November 13, 2018
Patent Application Number
15123059
Date Filed
March 9, 2015
Patent Citations Received
‌
US Patent 12116346 Human plasma kallikrein inhibitors
0
‌
US Patent 11685721 Human plasma kallikrein inhibitors
0
‌
US Patent 11708333 Human plasma kallikrein inhibitors
0
‌
US Patent 11708332 Human plasma kallikrein inhibitors
0
‌
US Patent 11230530 Human plasma kallikrein inhibitors
‌
US Patent 10633345 Human plasma kallikrein inhibitors
‌
US Patent 10662160 Crystalline salts of a plasma kallikrein inhibitor
‌
US Patent 10689346 Human plasma kallikrein inhibitors
...
Patent Primary Examiner
‌
Kamal A Saeed
Patent abstract

Disclosed are compounds of formula I

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10125102 Human plasma kallikrein inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.